Summary

U.S and Canada medical polymer resin and polymer value based product market is expected to reach USD 24.89 billion by 2032 from USD 19.45 billion in 2024, growing with a substantial CAGR of 3.21% in the forecast period of 2025 to 2032.

Market Segmentation:
U.S and Canada Medical Polymer Resin and Polymer Value Based Product Market Size, By Application (Medical Devices, Medical Devices Packaging, Medical Supplies and Consumables, Implants and Others), Category (Bottles, Syringes, Sachets, Bags, Pouches, Containers, Films, Trays, Vials, Ampoules and Others), Polymer Compound (Poly Vinyl Chloride (PVC), Polyethylene, Polypropylene, Polycarbonate, Polymethyl Methacrylate (PMMA), Fluoropolymers, Biomaterials, Polyethylene Teraphthalate Copolymer (PETG), Polyamide, Thermoplastic Elastomers, Silicone, Cellulose Based, Styrenics, Polyetheretherketone (PEEK), Sulfones, Polyester, Acetal, Liquid Crystal Polymer and Thermoset Elastomers), Countries (U.S. and Canada) – Industry Overview and Forecast to 2032

Some of the major factors contributing to the growth of the U.S and Canada medical polymer resin and polymer value based product market:

Driver
• Increasing demand for advanced medical devices and materials
Restraint
• Developing new medical polymers involves significant investment
Opportunitity
• Continuous innovations in polymer science and manufacturing technologies
Market Players:

The key players operating in the U.S and Canada medical polymer resin and polymer value based product market are:
• Exxon Mobil Corporation (U.S.)
• BASF (Germany)
• Dow (U.S.)
• INEOS AG (U.K.)
• Celanese Corporation (U.S.)
• SABIC (Saudi Arabia)
• Covestro AG (Germany)
• Eastman Chemical Company (U.S.)
• Mitsubishi Chemical Group Corporation. (Japan)
• Evonik Industries AG (Germany)
• China Petrochemical Corporation (China)
• DuPont (U.S.)
• dsm-firmenich (Switzerland)
• The Lubrizol Corporation (U.S.)
• Arkema (France)
• Formosa Plastics Corporation (China)
• Kraton Corporation (U.S.)
• Solvay (Belgium)
• M. Holland Company (U.S.)

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.3 OVERVIEW 26
1.4 LIMITATIONS 34
1.5 MARKETS COVERED 34
2 MARKET SEGMENTATION 92
2.1 MARKETS COVERED 92
2.2 GEOGRAPHICAL SCOPE 93
2.3 YEARS CONSIDERED FOR THE STUDY 93
2.4 CURRENCY AND PRICING 93
2.5 DBMR TRIPOD DATA VALIDATION MODEL 94
2.6 MULTIVARIATE MODELING 97
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 98
2.8 DBMR MARKET POSITION GRID 100
2.9 DBMR VENDOR SHARE ANALYSIS 101
2.10 MARKET APPLICATION COVERAGE GRID 102
2.11 SECONDARY SOURCES 103
2.12 ASSUMPTIONS 104
3 EXECUTIVE SUMMARY 105
4 PREMIUM INSIGHTS 110
4.1 PESTEL ANALYSIS 111
4.1.1 POLITICAL FACTORS 111
4.1.2 ECONOMIC FACTORS 111
4.1.3 SOCIAL FACTORS 112
4.1.4 TECHNOLOGICAL FACTORS 112
4.1.5 ENVIRONMENTAL FACTORS 112
4.1.6 LEGAL FACTORS 113
4.2 PORTER’S FIVE FORCES ANALYSIS 114
4.2.1 THREAT OF NEW ENTRANTS 114
4.2.2 BARGAINING POWER OF SUPPLIERS 114
4.2.3 BARGAINING POWER OF BUYERS 115
4.2.4 THREAT OF SUBSTITUTES 115
4.2.5 INTERNAL COMPETITION 115
4.3 IMPORT EXPORT SCENARIO 117
4.4 VENDOR SELECTION CRITERIA 118
4.4.1 COMPLIANCE WITH REGULATORY STANDARDS 118
4.4.2 TECHNOLOGICAL CAPABILITY AND INNOVATION 119
4.4.3 PRODUCT DURABILITY AND PERFORMANCE 119
4.4.4 COST-EFFECTIVENESS 119
4.4.5 TRACK RECORD AND REPUTATION 119
4.4.6 CUSTOMIZATION AND SCALABILITY 119
4.4.7 INTEGRATION AND INTEROPERABILITY 119
4.4.8 AFTER-SALES SUPPORT AND MAINTENANCE 120
4.4.9 FINANCIAL STABILITY 120
4.4.10 CONCLUSION 120
4.5 CLIMATE CHANGE SCENARIO 121
4.5.1 ENVIRONMENTAL CONCERNS 121
4.5.2 INDUSTRY RESPONSE 121
4.5.3 GOVERNMENT'S ROLE 121
4.5.4 ANALYST RECOMMENDATIONS 121
4.6 SUPPLY CHAIN ANALYSIS 122
4.6.1 OVERVIEW 122
4.6.2 LOGISTIC COST SCENARIO 122
4.6.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS 122
4.6.4 CONCLUSION 122
4.7 TECHNOLOGICAL ADVANCEMENTS BY MANUFACTURERS 123
4.7.1 ADVANCED MATERIALS FOR MEDICAL APPLICATIONS 123
4.7.2 3D PRINTING WITH MEDICAL POLYMERS 123
4.7.3 LIGHTWEIGHT AND DURABLE MEDICAL DEVICES 123
4.7.4 SUSTAINABLE AND ECO-FRIENDLY POLYMERS 123
4.7.5 SMART POLYMERS FOR ADVANCED HEALTHCARE 123
4.7.6 DIGITAL TECHNOLOGIES FOR QUALITY CONTROL 124
4.7.7 CONCLUSION 124
4.8 RAW MATERIAL COVERAGE 125
4.8.1 POLYETHYLENE (PE) 125
4.8.2 POLYPROPYLENE (PP) 125
4.8.3 POLYVINYL CHLORIDE (PVC) 125
4.8.4 POLYMETHYL METHACRYLATE (PMMA) 125
4.8.5 POLYCARBONATE (PC) 125
4.8.6 POLYAMIDE (NYLON) 126
4.8.7 POLYURETHANE (PU) 126
4.8.8 SILICONE 126
5 REGULATION COVERAGE 127
6 MARKET OVERVIEW 129
6.1 DRIVERS 131
6.1.1 INCREASING DEMAND FOR ADVANCED MEDICAL DEVICES AND MATERIALS 131
6.1.2 INCREASING ELDERLY POPULATION LEADS TO A HIGHER PREVALENCE OF CHRONIC DISEASES 131
6.1.3 RISE OF MINIMALLY INVASIVE PROCEDURES INCREASES THE NEED FOR SPECIALIZED MEDICAL POLYMERS 132
6.2 RESTRAINTS 133
6.2.1 DEVELOPING NEW MEDICAL POLYMERS INVOLVES SIGNIFICANT INVESTMENT 133
6.2.2 ENVIRONMENTAL SUSTAINABILITY CONCERNS 134
6.3 OPPORTUNITIES 135
6.3.1 CONTINUOUS INNOVATIONS IN POLYMER SCIENCE AND MANUFACTURING 135
6.3.2 ADVANCEMENTS IN 3D PRINTING TECHNOLOGY 135
6.4 CHALLENGES 136
6.4.1 CHALLENGE IN ENSURING REGULATORY COMPLIANCE 136
6.4.2 VOLATILITY IN RAW MATERIAL PRICES 137
7 U.S. AND CANADA MEDICAL POLYMER RESIN AND POLYMER VALUE BASED PRODUCTS MARKET, BY APPLICATION 139
7.1 OVERVIEW 140
7.2 MEDICAL DEVICES 142
7.3 MEDICAL DEVICES PACKAGING 148
7.4 MEDICAL SUPPLIES AND CONSUMABLES 153
7.5 IMPLANTS 230
7.6 OTHERS 249
8 U.S. AND CANADA MEDICAL POLYMER RESIN AND POLYMER VALUE BASED PRODUCTS MARKET, BY CATEGORY 254
8.1 OVERVIEW 255
8.2 BOTTLES 257
8.3 SYRINGES 257
8.4 SACHETS 257
8.5 BAGS 258
8.6 POUCHES 258
8.7 CONTAINERS 258
8.8 FILMS 258
8.9 TRAYS 258
8.10 VIALS 258
8.11 AMPOULES 258
8.12 OTHERS 258
9 U.S. AND CANADA MEDICAL POLYMER RESIN AND POLYMER VALUE BASED PRODUCTS MARKET, BY POLYMER COMPOUND 259
9.1 OVERVIEW 260
9.2 POLY VINYL CHLORIDE (PVC) 263
9.3 POLYETHYLENE 263
9.4 POLYPROPYLENE 263
9.5 POLYCARBONATE 263
9.6 POLYMETHYL METHACRYLATE (PMMA) 263
9.7 FLUOROPOLYMERS 264
9.8 BIOMATERIALS 265
9.9 POLYETHYLENE TEREPHTHALATE COPOLYMER (PETG) 265
9.10 POLYAMIDE 265
9.11 THERMOPLASTIC ELASTOMERS 266
9.12 SILICONE 266
9.13 CELLULOSE BASED 267
9.14 STYRENICS 267
9.15 POLYETHERETHERKETONE (PEEK) 267
9.16 SULFONES 268
9.17 POLYESTER 268
9.18 ACETAL 268
9.19 LIQUID CRYSTAL POLYMER 269
9.20 THERMOSET ELASTOMERS 269
10 U.S AND CANADA MEDICAL POLYMER RESIN AND POLYMER VALUE BASED PRODUCT MARKET: COMPANY LANDSCAPE 270
10.1 COMPANY SHARE ANALYSIS: U.S. & CANADA 270
10.2 COMPANY SHARE ANALYSIS: U.S MEDICAL POLYMER RESIN AND POLYMER VALUE BASED PRODUCT MARKET 271
10.3 COMPANY SHARE ANALYSIS: CANADA MEDICAL POLYMER RESIN AND POLYMER VALUE BASED PRODUCT MARKET 272
10.4 COMPANY SHARE ANALYSIS: U.S MEDICAL POLYMER RESIN MARKET 273
10.5 COMPANY SHARE ANALYSIS: CANADA MEDICAL POLYMER RESIN MARKET 274
11 SWOT ANALYSIS 275
12 COMPANY PROFILES 276
12.1 EXXON MOBIL CORPORATION 276
12.1.1 COMPANY SNAPSHOT 276
12.1.2 REVENUE ANALYSIS 276
12.1.3 PRODUCT PORTFOLIO 277
12.1.4 RECENT DEVELOPMENT 277
12.2 BASF 278
12.2.1 COMPANY SNAPSHOT 278
12.2.2 REVENUE ANALYSIS 278
12.2.3 PRODUCT PORTFOLIO 279
12.2.4 RECENT DEVELOPMENT 280
12.3 DOW 281
12.3.1 COMPANY SNAPSHOT 281
12.3.2 REVENUE ANALYSIS 281
12.3.3 PRODUCT PORTFOLIO 282
12.3.4 RECENT DEVELOPMENT 282
12.4 INEOS AG 283
12.4.1 COMPANY SNAPSHOT 283
12.4.2 REVENUE ANALYSIS 283
12.4.3 PRODUCT PORTFOLIO 284
12.4.4 RECENT DEVELOPMENT 284
12.5 SABIC 285
12.5.1 COMPANY SNAPSHOT 285
12.5.2 REVENUE ANALYSIS 285
12.5.3 PRODUCT PORTFOLIO 286
12.5.4 RECENT DEVELOPMENT 288
12.6 ARKEMA 289
12.6.1 COMPANY SNAPSHOT 289
12.6.2 REVENUE ANALYSIS 289
12.6.3 PRODUCT PORTFOLIO 290
12.6.4 RECENT DEVELOPMENT 291
12.7 CELANESE CORPORATION 292
12.7.1 COMPANY SNAPSHOT 292
12.7.2 REVENUE ANALYSIS 292
12.7.3 PRODUCT PORTFOLIO 293
12.7.4 RECENT DEVELOPMENT 293
12.8 CHINA PETROCHEMICAL CORPORATION 294
12.8.1 COMPANY SNAPSHOT 294
12.8.2 REVENUE ANALYSIS 294
12.8.3 PRODUCT PORTFOLIO 295
12.8.4 RECENT DEVELOPMENT 295
 
12.9 COVESTRO AG 296
12.9.1 COMPANY SNAPSHOT 296
12.9.2 REVENUE ANALYSIS 297
12.9.3 PRODUCT PORTFOLIO 297
12.9.4 RECENT DEVELOPMENT 298
12.10 DSM-FIRMENICH 299
12.10.1 COMPANY SNAPSHOT 299
12.10.2 REVENUE ANALYSIS 299
12.10.3 PRODUCT PORTFOLIO 300
12.10.4 RECENT DEVELOPMENT 300
12.11 DUPONT 301
12.11.1 COMPANY SNAPSHOT 301
12.11.2 REVENUE ANALYSIS 301
12.11.3 PRODUCT PORTFOLIO 302
12.11.4 RECENT DEVELOPMENT 303
12.12 EASTMAN CHEMICAL COMPANY 304
12.12.1 COMPANY SNAPSHOT 304
12.12.2 REVENUE ANALYSIS 304
12.12.3 PRODUCT PORTFOLIO 305
12.12.4 RECENT DEVELOPMENT 305
12.13 EVONIK INDUSTRIES AG 306
12.13.1 COMPANY SNAPSHOT 306
12.13.2 REVENUE ANALYSIS 306
12.13.3 PRODUCT PORTFOLIO 307
12.13.4 RECENT DEVELOPMENT 307
12.14 FORMOSA PLASTICS CORPORATION 308
12.14.1 COMPANY SNAPSHOT 308
12.14.2 REVENUE ANALYSIS 309
12.14.3 PRODUCT PORTFOLIO 309
12.14.4 RECENT DEVELOPMENT 311
12.15 KRATON CORPORATION 313
12.15.1 COMPANY SNAPSHOT 313
12.15.2 PRODUCT PORTFOLIO 313
12.15.3 RECENT DEVELOPMENT 315
12.16 M. HOLLAND COMPANY 316
12.16.1 COMPANY SNAPSHOT 316
12.16.2 PRODUCT PORTFOLIO 316
12.16.3 RECENT DEVELOPMENT 317
 
12.17 MITSUBISHI CHEMICAL GROUP CORPORATION 318
12.17.1 COMPANY SNAPSHOT 318
12.17.2 REVENUE ANALYSIS 319
12.17.3 PRODUCT PORTFOLIO 319
12.17.4 RECENT DEVELOPMENT 320
12.18 SOLVAY 321
12.18.1 COMPANY SNAPSHOT 321
12.18.2 REVENUE ANALYSIS 321
12.18.3 PRODUCT PORTFOLIO 322
12.18.4 RECENT DEVELOPMENT 322
12.19 THE LUBRIZOL CORPORATION 323
12.19.1 COMPANY SNAPSHOT 323
12.19.2 PRODUCT PORTFOLIO 323
12.19.3 RECENT DEVELOPMENT 324
13 QUESTIONNAIRE 325
14 RELATED REPORTS 328